BioCardia Files 8-K: Regulation FD & Financials
Ticker: BCDA · Form: 8-K · Filed: May 1, 2025 · CIK: 925741
| Field | Detail |
|---|---|
| Company | Biocardia, Inc. (BCDA) |
| Form Type | 8-K |
| Filed Date | May 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, financials
Related Tickers: BCDA
TL;DR
BioCardia filed an 8-K for Reg FD and financials. Nothing major disclosed in this snippet.
AI Summary
On April 30, 2025, BioCardia, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits. No specific material events or financial figures were detailed in the provided excerpt.
Why It Matters
This filing indicates BioCardia is adhering to regulatory disclosure requirements, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of financial statements and exhibits, not indicating any immediate material changes or risks.
Key Players & Entities
- BioCardia, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 320 Soquel Way Sunnyvale, California 94085 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for BioCardia, Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
What is BioCardia, Inc.'s principal executive office address?
BioCardia, Inc.'s principal executive office is located at 320 Soquel Way, Sunnyvale, California 94085.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on April 30, 2025.
What is BioCardia, Inc.'s Commission File Number?
BioCardia, Inc.'s Commission File Number is 001-38999.
What is BioCardia, Inc.'s IRS Employer Identification No.?
BioCardia, Inc.'s IRS Employer Identification No. is 23-2753988.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 1, 2025 regarding BioCardia, Inc. (BCDA).